Global Glioma Therapeutics Market 2019-2023

Friday, January 4, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Jan. 3, 2019 /PRNewswire/ -- About this marketStrategic alliances to drive growth in the market. Pharmaceutical

companies are collaborating to develop medications for the treatment of glioma. These alliances can enhance R&D activities for new drugs for the treatment of glioma. Technavio' s analysts have predicted that the glioma therapeutics market will register
a CAGR of more than 9% by 2023.Download the full report: https://www.reportbuyer.com/product/5678767 Market OverviewExpected approval of late-stage pipeline moleculesAs the market is currently experiencing an acute lack of approved therapies, these late-stage pipeline molecules can tap into this unmet demand from the glioma patient pool. Once these molecules are launched during the forecast period, the global glioma therapeutics market should observe strong value growth from these newly launched therapeutics.Availability of alternative therapiesDespite the availability of medications for the treatment of the glioma, there are several alternative procedures. The high cost, side effects, and long duration of treatment with the available medications are increasing patients' inclination toward the surgical and radiation treatment options.For the detailed list of factors that will drive and challenge the growth of the glioma therapeutics market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be fragmented and with the presence of several companies including NextSource Biotechnology and Novartis the competitive environment is quite intense. Factors such as the expected approval of late-stage pipeline molecules and the strategic alliances, will provide considerable growth opportunities to glioma therapeutics manufactures. F. Hoffmann-La Roche, Merck Sharp & Dohme, Mylan, NextSource Biotechnology, and Novartis are some of the major companies covered in this report.Download the full report: https://www.reportbuyer.com/product/5678767 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/global-glioma-therapeutics-market-2019-2023-300772490.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store